dipyridamole has been researched along with Agnogenic Myeloid Metaplasia in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, MS | 1 |
| Christensen, BE | 1 |
| Jønsson, V | 1 |
| Kuramoto, A | 1 |
| Taketomi, Y | 1 |
| Nakagawa, J | 1 |
| Uchino, H | 1 |
2 other studies available for dipyridamole and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
The effect of acetyl salicylic acid and dipyridamole on thromboembolic complications in splenectomized patients with myelofibrosis.
Topics: Aged; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Drug Therapy, Combination; Female; Huma | 1979 |
Metabolic and kinetic study of thrombogenesis: regulatory mechanism in early step of platelet plug formation.
Topics: Adult; Aged; Blood Platelets; Dipyridamole; Epinephrine; Female; Glycolysis; Humans; Leukemia, Myelo | 1976 |